Skip to main content
. Author manuscript; available in PMC: 2021 Mar 24.
Published in final edited form as: Circulation. 2020 Jan 14;141(12):957–967. doi: 10.1161/CIRCULATIONAHA.119.043628

Figure 1.

Figure 1.

Prevalence of the malignant left ventricular hypertrophy (LVH) phenotype (evidence of LVH, with either high-sensitivity cardiac troponin-T (hs-cTnT) ≥ 6 and N-terminal pro-brain natriuretic peptide (NT-proBNP) ≥ 100) among men and women stratified by race/ethnicity.